Surgery Partners (SGRY) Common Equity (2013 - 2026)

Surgery Partners has disclosed Common Equity across 14 years of filings, most recently posting $3.1 billion for Q1 2026.

• Common Equity for Q1 2026 came in at $3.1 billion, down 1.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (down 1.84% YoY), and the FY2025 annual result was $3.1 billion, down 2.04% from the prior year.
• Common Equity came in at $3.1 billion for Q1 2026 at Surgery Partners, down from $3.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $3.2 billion in Q4 2024 to a low of $1.7 billion in Q3 2025.
• The 5-year median for Common Equity is $3.0 billion (2023), against an average of $2.8 billion.
• Across the five-year window, Common Equity soared 82.09% in 2022 and plunged 44.42% in 2025, its largest moves.
• Surgery Partners' Common Equity stood at $2.9 billion in 2022, then advanced by 3.18% to $3.0 billion in 2023, then advanced by 5.34% to $3.2 billion in 2024, then decreased by 2.04% to $3.1 billion in 2025, then declined by 1.07% to $3.1 billion in 2026.
• The last three Common Equity figures came in at $3.1 billion (Q1 2026), $3.1 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.